Numerous efforts have been devoted to optimizing the structure of CAR NK to alleviate immunosuppression and enhance their anti-tumor activity, including using advanced genetic engineering techniques to enable NK cells to simultaneously express IL-15 or knock out checkpoint molecules. Here, IL15 is linked to neoplasm.